8-133131869-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003235.5(TG):​c.7920C>T​(p.Tyr2640Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.466 in 1,613,812 control chromosomes in the GnomAD database, including 180,679 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.49 ( 18754 hom., cov: 32)
Exomes 𝑓: 0.46 ( 161925 hom. )

Consequence

TG
NM_003235.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.250

Publications

14 publications found
Variant links:
Genes affected
TG (HGNC:11764): (thyroglobulin) Thyroglobulin (Tg) is a glycoprotein homodimer produced predominantly by the thryroid gland. It acts as a substrate for the synthesis of thyroxine and triiodothyronine as well as the storage of the inactive forms of thyroid hormone and iodine. Thyroglobulin is secreted from the endoplasmic reticulum to its site of iodination, and subsequent thyroxine biosynthesis, in the follicular lumen. Mutations in this gene cause thyroid dyshormonogenesis, manifested as goiter, and are associated with moderate to severe congenital hypothyroidism. Polymorphisms in this gene are associated with susceptibility to autoimmune thyroid diseases (AITD) such as Graves disease and Hashimoto thryoiditis. [provided by RefSeq, Nov 2009]
TG Gene-Disease associations (from GenCC):
  • thyroid dyshormonogenesis 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial thyroid dyshormonogenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • thyroid cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 8-133131869-C-T is Benign according to our data. Variant chr8-133131869-C-T is described in ClinVar as Benign. ClinVar VariationId is 259003.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.25 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.577 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGNM_003235.5 linkc.7920C>T p.Tyr2640Tyr synonymous_variant Exon 46 of 48 ENST00000220616.9 NP_003226.4 P01266-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGENST00000220616.9 linkc.7920C>T p.Tyr2640Tyr synonymous_variant Exon 46 of 48 1 NM_003235.5 ENSP00000220616.4 P01266-1

Frequencies

GnomAD3 genomes
AF:
0.487
AC:
73948
AN:
151878
Hom.:
18735
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.583
Gnomad AMI
AF:
0.370
Gnomad AMR
AF:
0.452
Gnomad ASJ
AF:
0.567
Gnomad EAS
AF:
0.165
Gnomad SAS
AF:
0.309
Gnomad FIN
AF:
0.378
Gnomad MID
AF:
0.522
Gnomad NFE
AF:
0.487
Gnomad OTH
AF:
0.508
GnomAD2 exomes
AF:
0.428
AC:
107635
AN:
251420
AF XY:
0.425
show subpopulations
Gnomad AFR exome
AF:
0.586
Gnomad AMR exome
AF:
0.384
Gnomad ASJ exome
AF:
0.554
Gnomad EAS exome
AF:
0.170
Gnomad FIN exome
AF:
0.385
Gnomad NFE exome
AF:
0.487
Gnomad OTH exome
AF:
0.458
GnomAD4 exome
AF:
0.464
AC:
677945
AN:
1461816
Hom.:
161925
Cov.:
55
AF XY:
0.460
AC XY:
334335
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.591
AC:
19789
AN:
33480
American (AMR)
AF:
0.401
AC:
17913
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.555
AC:
14514
AN:
26136
East Asian (EAS)
AF:
0.129
AC:
5130
AN:
39700
South Asian (SAS)
AF:
0.321
AC:
27720
AN:
86256
European-Finnish (FIN)
AF:
0.394
AC:
21042
AN:
53416
Middle Eastern (MID)
AF:
0.522
AC:
3011
AN:
5766
European-Non Finnish (NFE)
AF:
0.486
AC:
540380
AN:
1111946
Other (OTH)
AF:
0.471
AC:
28446
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
21736
43473
65209
86946
108682
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15704
31408
47112
62816
78520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.487
AC:
73999
AN:
151996
Hom.:
18754
Cov.:
32
AF XY:
0.475
AC XY:
35323
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.583
AC:
24181
AN:
41450
American (AMR)
AF:
0.451
AC:
6895
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.567
AC:
1966
AN:
3470
East Asian (EAS)
AF:
0.164
AC:
847
AN:
5160
South Asian (SAS)
AF:
0.309
AC:
1488
AN:
4812
European-Finnish (FIN)
AF:
0.378
AC:
3983
AN:
10544
Middle Eastern (MID)
AF:
0.517
AC:
152
AN:
294
European-Non Finnish (NFE)
AF:
0.487
AC:
33090
AN:
67976
Other (OTH)
AF:
0.503
AC:
1060
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1869
3738
5606
7475
9344
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
650
1300
1950
2600
3250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.467
Hom.:
48471
Bravo
AF:
0.497
Asia WGS
AF:
0.239
AC:
830
AN:
3476
EpiCase
AF:
0.489
EpiControl
AF:
0.489

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 26, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Iodotyrosyl coupling defect Benign:2
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
5.6
DANN
Benign
0.47
PhyloP100
-0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2294024; hg19: chr8-134144113; COSMIC: COSV55069942; COSMIC: COSV55069942; API